Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Central Admixture Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc. Recalls

All product recalls associated with Central Admixture Pharmacy Services, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

346

Past Year

Class I (Serious)

Most Recent

Jul 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 301–320 of 346 recalls

Heparin Sodium Chloride (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Phenylephrine Sodium Chloride (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Potassium Acetate Injection (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

1...14 151617 18

Page 16 of 18Next

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Tromethamine Injection (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Oxytocin Sodium Chloride (Central Admixture) – Sterility Concern (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Warm Induction Solution (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Norepinephrine Dextrose Injection (Central Admixture) – sterility risk (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.